STOCK TITAN

BCAX (BCAX) Form 144 shows option exercises and Ryan Cohlhepp sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BCAX files Form 144 reporting proposed sales of Common stock and recent dispositions by a holder. The filing lists securities to be sold from option exercises including 05/12/2024 (4,500 shares) and 03/16/2026 (8,000 shares). It also reports actual Common stock sales by Ryan Cohlhepp on 01/15/2026 (149 shares, $2,684.98), 01/22/2026 (3,828 shares, $69,295.99), 02/25/2026 (3,631 shares, $69,132.42), and 03/03/2026 (17,392 shares, $315,892.64).

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists proposed resale of shares from option exercises and several completed sales by a named holder.

The filing records two option-exercise related sale entries: 05/12/2024 for 4,500 shares and 03/16/2026 for 8,000 shares. These are described as "Exercise of Stock Option" with cash consideration.

Separately, the excerpt lists four completed sales by Ryan Cohlhepp with exact share counts and proceeds. The filing provides transaction dates and gross proceeds amounts; it does not state any qualifying conditions or counsel opinion within the provided excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does BCAX's Form 144 disclose about proposed sales?

The Form 144 discloses proposed sales tied to option exercises of 4,500 shares on 05/12/2024 and 8,000 shares on 03/16/2026. It labels these as "Exercise of Stock Option" with cash consideration.

Who reported recent sales in the BCAX filing and how many shares were sold?

The filing reports sales by Ryan Cohlhepp: 149, 3,828, 3,631, and 17,392 shares on the listed dates. Each sale row includes the gross proceeds amount.

What proceeds are shown for the largest reported sale in the BCAX excerpt?

The largest reported sale is 17,392 shares on 03/03/2026 with gross proceeds of $315,892.64. Each sale line lists the corresponding proceeds in dollars.

Are the proposed sales described as issuer or holder transactions in BCAX's filing?

The two option-related entries are labeled as Issuer actions with the method "Exercise of Stock Option." The sale history rows list an individual holder, indicating those are reported dispositions by that holder.
Bicara Therapeutics

NASDAQ:BCAX

View BCAX Stock Overview

BCAX Rankings

BCAX Latest News

BCAX Latest SEC Filings

BCAX Stock Data

1.19B
53.43M
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON